join the sweet revolution in biopharmaceuticals...resolution/accurate mass (hr/am) mass spectrometry...

7
Thermo Scientific Glycan Analysis for Biotherapeutics • Intact Glycoproteins • Glycopeptides • Free Glycans • Monosacccharides Join the sweet revolution in biopharmaceuticals

Upload: others

Post on 31-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

Thermo ScientificGlycan Analysis for Biotherapeutics

• Intact Glycoproteins• Glycopeptides • Free Glycans• Monosacccharides

Join the sweet revolution in biopharmaceuticals

Page 2: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

Biotherapeutic proteins, which include

antibodies, are becoming the fastest growing

category of drugs due to their efficacy

for patient health. The complex nature of

these large molecules brings major new

challenges to the pharmaceutical scientist.

The industry is undergoing a scientific

revolution as it adapts to meet the challenges

of characterizing biotherapeutics.

WHAT IS MY GLYCOSYLATION PATTERN? Intact Glycoprotein analysis

1WHERE DO MY GLYCANS RESIDE? Glycopeptide profiling

22 3

Glycosylation of biotherapeutic medicines

plays a critical role in the efficacy of the drug.

In-depth characterization of these glycans (complex sugars) bound to the drug entity is mandatory and challenging. To overcome this challenge, we have developed a series of four simple workflow solutions based on leading technology platforms.

THE CHALLENGES of Glycan Characterization

MEETING

4WHAT IS THE COMPOSITION OF SUGARS IN MY DRUG ENTITY? Monosaccharide analysis

WHICH GLYCANS ARE IN MY DRUG AND WHAT IS THEIR CONCENTRATION? Glycan structure determination

3

Page 3: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

Analyze Intact ProteinsMany biopharmaceutical and biological research applications require analysis of proteins in their native (intact) state. The Thermo Scientific™ Exactive™ Plus EMR mass spectrometer combines unsurpassed high-resolution accurate-mass analysis with an extended mass range (EMR) to create an outstanding tool for investigating the structure, topology, and architecture of native-like tertiary and quaternary protein structures. A superb tool for high-performance screening of monoclonal antibodies, antibody-drug conjugates (ADC), PEG-ylated proteins, oligomerized protein-based drugs and glycoforms.

Deconvolute Protein SpectraScreen, identify, and characterize intact proteins with higher productivity and confidence using Thermo Scientific™ Protein Deconvolution software. The software uses not one, but two deconvolution algorithms. One algorithm to take full advantage of the high-quality, high-resolution accurate-mass (HRAM) data produced by Thermo Scientific™ Orbitrap™ based mass spectrometers. The second algorithm is for lower resolution spectra where the mass spectral peaks are not isotopically resolved.

INTACT GLYCOPROTEINIsolated antibodies and large proteins are often chemically reduced prior to analysis.

SEPARATE GLYCOPROTEINSAdvanced ion exchange or hydrophobic interaction chromatography columns allow full separation of antibody fragments.

LIQUID CHROMATOGRAPHYReproducible, bio-compatible chromatography is required to simplify variants.

CONFIRM MASS OF GLYCOPROTEINHigh resolution and mass accuracy are required together with deconvolution software to interpret spectra.

4 5

IS MY Glycosylation Pattern?

WHAT

Intact Glycoprotein Analysis Workflow

Extended mass range (EMR) of up to m/z 20,000 and improved detection of high-mass ions.

Analyze with Mass Spectrometry Intact glycoprotein profiling is used to ascertain the pattern and degree of glycosylation. Due to the heterogeneity of the attached glycan moieties, intact glycoprotein profiling is best performed using high resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various glycoforms present on a protein or antibody.

3260 3270 3280 3290m/z

0 10 20 30 40 50 60

70

80 90

100

Rela

tive

Abun

danc

e

3272.96 3276.58

3269.31 3280.12

3283.743266.23 3290.26

zoom

2500 3000 3500 4000 m/z

0 10 20 30 40 50 60 70 80 90

100

Rela

tive

Abun

danc

e

3272.96

3347.33 3137.16

3425.13 3068.50 3005.83 3506.59

3592.19 2945.77 3686.06 2888.16

3776.35 2832.49 3875.98 2776.10

3984.74 2632.99 4208.14 2303.96

146925.606146619.406 148010.563162 Da 162 Da162 Da 162 Da162 Da

146619.406Man5/Man5

(G1F/G2F)SA1

(G1F/G2F)SA2

G1F/G2FSA2

G1F/G2FSA1

146541.406

146925.606

Man5/Man5(G2F/G2F)SA2

+2740.35+2673.54

+2513.07

(G2F/G2F)SA1

100

80

60

40

20

0

0

1

2

3

4

146600mass

mass

abun

danc

eab

unda

nce

146800 147000 147200 147400 147600 147800 148000 148200

146600

146698.328

146858.797

147075.969 147237.734 147399.516 147561.766 147721.813 147854.688

148010.563 148144.984148307.484

146800 147000 147200 147400 147600 147800 148000 148200

146698.328 146858.797

147075.969

147237.734147399.516

147561.766

147721.813147854.688 148144.984 148307.484

NL: 9.34E7

NL: 9.34E7

162 Da

Spectrum of Rituximab. Insert shows the different glycoforms of the molecule.

Deconvoluted spectrum of rituximab glycoforms confirmed with accurate mass.

Separate Antibody Variants & Fragments Thermo Scientific™ MAbPac™ columns are designed for the separation of monoclonal antibodies (mAbs) and related biologics by hydrophobic interaction (HIC), ion exchange (IEC), size exclusion (SEC) and reverse phase (RP) chromatography. This suite of columns have unique chemistries to provide high resolution, excellent bio-compatibility, and complementary selectivity suitable for a broad range of assays for mAbs and related substances.

0.0 1.3 2.5 3.8 5.0 6.3 7.5 8.8 10.0 12.0

Cetuximab - MAbPac RP

min

5.00 5.50 6.00 6.50 7.00 7.50 8.000.0

10.0

20.0

30.0

40.0

50.0 MABPacRP #17 CET UV_VIS_1mAU

min

WVL:214 nm

Separation of Cetuximab variants using a MAbPac RP column.

Page 4: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

ANALYZE AND MAP

Glycopeptide mapping can be performed rapidly and accurately with the combination of any of our Thermo Scientific™ Q Exactive™ family of Orbitrap powered mass spectrometers, combined with the latest software for comprehensive mapping of biotherapeutic proteins - PepFinder.

For more advanced characterization of an intact glycopeptide, multiple fragmentations are required: HCD Higher-energy collisional dissociation provides information about the glycan composition and ETD (electron transfer dissociation) provides extensive fragmentation along the peptide batckbone to enable sequencing of the peptide while preserving attachment of the glycans, allowing localization of the glycosylation sites. ETD is available on Thermo Scientific™ Orbitrap Fusion Lumos™ Tribrid™ MS.

INTACT GLYCOPROTEINIsolate antibody or glycoprotein.

DIGEST TO GLYCOPEPTIDESReproducible, fast, digestion in less than one hour.

SEPARATE GLYCOPEPTIDESGlycopeptides can be separated faster using advanced UHPLC columns.

ANALYZE & MAPRoutine peptide mapping provides protein sequence incluiding glycopetides.Advanced MS fragmentation provides exact glycopeptide location information.

7

DO MY Glycans Reside?

WHERE

Glycopeptide Mapping Workflow

Glycan analysis can also be performed at the peptide level, with the goal of obtaining both glycan composition and peptide sequence at the site of glycosylation.

DIGEST

Thermo Scientific™ SMART Digest™ kits are designed for biopharmaceutical applications that require highly reproducible, sensitive and fast analysis, often in high throughput workflows. The kit uses unique optimized heat-stable immobilized trypsin technology.

SMART Digest allows complete antibody digestion in just 60 minutes; a saving of up to 23 hours versus in-solution digestion methods.

SEPARATE PEPTIDES

The glycopeptides can then be separated in a few minutes with the highest speed and resolution using the biocompatible Thermo Scientific™ Vanquish™ UHPLC system together with Thermo Scientific™ Accucore™ C18 or Acclaim 120 RS UHPLC columns.

Determine the Exact Location of GlycosylationThe Orbitrap Fusion Lumos Tribrid MS is the most sensitive Orbitrap instrument available and can perform a wide variety of analyses, from in-depth discovery experiments to characterization of complex PTMs to comprehensive qual/quan workflows. The availability of multiple fragmentation techniques - CID, HCD, ETD; combined ionization spectra such as EThcD; and also product dependent acquisition (such as HCDpdETD), which generates a pair of HCD and ETD spectra. At any stage of MSn, with fragment ion detection in either the ion trap or Orbitrap mass analyzer, offers a new level of versatility and performance for the most challenging applications. Such as, the identification and location of glycosylated peptides.

Resolution up to 500,000 FWHM and exceptional <1 ppm mass accuracy provides absolute confidence in glycopeptide identification.

6

Simple, Advanced Peptide Mapping Software Thermo Scientific™ PepFinder™ software provides accurate identification, in-depth characterization, and relative quantitation of biotherapeutic and other proteins from mass spectrometric data. It provides an automated workflow for glycopeptide identification, disulfide bond mapping, and quantification of PTMs. PepFinder software automates previously time-consuming manual processes, processing complex data and integrating the results into concise, informative reports.

200 400 600 800 1000 1200 1400 1600 1800 2000m/z

0

10

20

30

40

50

60

70

80

90

100

Rela

tive

Abu

ndan

ce

C7H

8NO

2

z1 Hex

NAc

-36

y1b2

Hex

NAc

b3

c3N

euAc

-18

Neu

Ac

z2 y2c6++

c4c8++

Hex

NAc

Hex

y7++c9++

z3y3

c11++

c10++

c5

z9++y9++

z4z10++ Hex

Hex

NAc

Neu

Ac

z15++c14++b14++

z11++

c13++c12++

M+e

-Neu

Ac

M+2

e-N

euAc

c13+++

c14+++

z12+++z13+++z14+++

c18+++_Iso1c19+++_Iso1z18+++_Iso1M

+3e-

Neu

Ac

c20+++_Iso1

M_5

+ - H

exN

AcH

exM

_5+

- Neu

Ac(2

)M

_5+

- Hex

NAc

Hex

Neu

Ac

y6z6c7Pep

+Hex

NAc

4+

c6z7c9 b10z8 z21+++_Iso1

c21+++_Iso1y7

G H G H R N G T G H G N S T H H G P E Y M REThcD

z17+++_Iso1

M+e

M+2

e

M+3

e

200 400 600 800 1000 1200 1400 1600 1800 2000m/z

0

5

10

15

20

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100

Rela

tive

Abu

ndan

ce

C6H

8NO

2C7

H8N

O2

Hex

Hex

NAc

-36

Hex

NAc

-18

Hex

NAc

y1b2

Neu

Ac-1

8N

euAc

b6++

Hex

NAc

Hex

y7++y3

b5 Pep+

Hex

NAc

4+

Hex

Neu

AcH

exN

Ac

b6

y5 Pep+

2Hex

NAc

4+

y6Pep+

2Hex

NAc

+2H

ex4+

Pep3+

Pep+

2Hex

NAc

+3H

ex4+

Pep+

Hex

NAc

3+

Pep+

3Hex

NAc

+3H

ex4+

y7b9 Pep+

3Hex

NAc

+4H

ex4+

Pep+

2Hex

NAc

3+

Pep+

2Hex

NAc

+Hex

3+

Pep+

2Hex

NAc

+2H

ex3+

Pep+

2Hex

NAc

+3H

ex3+

Pep+

3Hex

NAc

+3H

ex3+

Pep2+

Pep+

3Hex

NAc

+4H

ex3+

Pep+

Hex

NAc

2+

Pep+

2Hex

NAc

2+

Pep+

2Hex

NAc

+Hex

2+

Pep+

2Hex

NAc

+2H

ex2+

Pep+

2Hex

NAc

+3H

ex2+

b16

G H G H R N G T G H G N S T H H G P E Y M RHCD

200 400 600 800 1000 1200 1400 1600 1800 2000m/z

0

5

10

15

20

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100

Rela

tive

Abu

ndan

ce

z1

y1

c2

c3

z2y2

c4

c8++

z3

y3z8++

c10++

c11++

c5

z4

z10++c6y5c7y6z6

c8

z7

y7c9z8

c10

c11 c12++c14++

G H G H R N G T G H G N S T H H G P E Y M R

z9++

ETD

200 400 600 800 1000 1200 1400 1600 1800 2000m/z

0

10

20

30

40

50

60

70

80

90

100

Rela

tive

Abu

ndan

ce

C7H

8NO

2

z1 Hex

NAc

-36

y1b2

Hex

NAc

b3

c3N

euAc

-18

Neu

Ac

z2 y2c6++

c4c8++

Hex

NAc

Hex

y7++c9++

z3y3

c11++

c10++

c5

z9++y9++

z4z10++ Hex

Hex

NAc

Neu

Ac

z15++c14++b14++

z11++

c13++c12++

M+e

-Neu

Ac

M+2

e-N

euAc

c13+++

c14+++

z12+++z13+++z14+++

c18+++_Iso1c19+++_Iso1z18+++_Iso1M

+3e-

Neu

Ac

c20+++_Iso1

M_5

+ - H

exN

AcH

exM

_5+

- Neu

Ac(2

)M

_5+

- Hex

NAc

Hex

Neu

Ac

y6z6c7Pep

+Hex

NAc

4+

c6z7c9 b10z8 z21+++_Iso1

c21+++_Iso1y7

G H G H R N G T G H G N S T H H G P E Y M REThcD

z17+++_Iso1

M+e

M+2

e

M+3

e

200 400 600 800 1000 1200 1400 1600 1800 2000m/z

0

5

10

15

20

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100

Rela

tive

Abu

ndan

ce

C6H

8NO

2C7

H8N

O2

Hex

Hex

NAc

-36

Hex

NAc

-18

Hex

NAc

y1b2

Neu

Ac-1

8N

euAc

b6++

Hex

NAc

Hex

y7++y3

b5 Pep+

Hex

NAc

4+

Hex

Neu

AcH

exN

Ac

b6

y5 Pep+

2Hex

NAc

4+

y6Pep+

2Hex

NAc

+2H

ex4+

Pep3+

Pep+

2Hex

NAc

+3H

ex4+

Pep+

Hex

NAc

3+

Pep+

3Hex

NAc

+3H

ex4+

y7b9 Pep+

3Hex

NAc

+4H

ex4+

Pep+

2Hex

NAc

3+

Pep+

2Hex

NAc

+Hex

3+

Pep+

2Hex

NAc

+2H

ex3+

Pep+

2Hex

NAc

+3H

ex3+

Pep+

3Hex

NAc

+3H

ex3+

Pep2+

Pep+

3Hex

NAc

+4H

ex3+

Pep+

Hex

NAc

2+

Pep+

2Hex

NAc

2+

Pep+

2Hex

NAc

+Hex

2+

Pep+

2Hex

NAc

+2H

ex2+

Pep+

2Hex

NAc

+3H

ex2+

b16

G H G H R N G T G H G N S T H H G P E Y M RHCD

200 400 600 800 1000 1200 1400 1600 1800 2000m/z

0

5

10

15

20

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100

Rela

tive

Abu

ndan

ce

z1

y1

c2

c3

z2y2

c4

c8++

z3

y3z8++

c10++

c11++

c5

z4

z10++c6y5c7y6z6

c8

z7

y7c9z8

c10

c11 c12++c14++

G H G H R N G T G H G N S T H H G P E Y M R

z9++

ETD

Multiple fragmentation techniques allow unambiguous assignment of glycosylation site.

Page 5: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

ANALYZE LC

ANALYZE LC-MSINTACT GLYCOPROTEINIsolate antibody or glycoprotein.

RELEASE GLYCANSGlycans are released enzymatically using glycosidase.

LABEL GLYCANSChemically react to add either a fluorophore or aminoxy tandem mass tag (TMT).

SEPARATESelective chemistries using combined HIC/WAX phases provide exceptional glycan separations.

ANALYZE & QUANTIFYSeparate and detect fluorescence labelled glycans.

9

ARE IN MY DRUG AND what is their concentration?

WHICH GLYCANS

Free Glycan Analysis Workflow

Monitoring of specifc glycan species or determination of relative quantities of a particular set of glycans provides important information for the development of biotherapeutics. Due to the complexity of glycan structures, quantiation and identification is performed upon release of glycans from the protein. N-linked glycans are released by enzymatic treartment, whereas O-linked glycans needs to be relased by chemical method as no enzyme exists for this purpose.

Glycans have no chromophore and have a poor response with conventional LC-UV detection. Glycans can be labelled with fluorescent tags prior to high sensitivity analysis by LC-Fluorescence detection. The most common label being 2-aminobenzamide (2-AB). Mass spectrometry has emerged as one of the most powerful tools for glycan structure elucidation. However, as most glycans do not ionize efficiently 2-AB labelling can also be performed to improve sensitivity. Thermo Scientific™ aminoxyTMT™ (Tandem Mass Tag™) reagents can also be used for labeling proteins or released glycans. This enables multiplexing experiments to be performed for quantitation of glycans by mass spectrometry.

Revolutionize Your UHPLC Experience

The Vanquish UHPLC system takes biomolecule separations to a new level. The system offers better, faster, separations than previously possible. The system has exceptional control and stability giving you unrivalled reproducibility for meaningful answers.

• Maximized separation power, flow and gradient precision• Controlled separations with reproducible thermostatting• Analyze more samples with Vanquish Charger module• Compliant Thermo Scientific™ Chromeleon™ CDS software

GlycanPac AXH-1 & AXR-1 ColumnsThermo Scientific™ GlycanPac™ AXR-1 and GlycanPac AXH-1 columns are high-performance, silica-based HPLC columns designed for high-resolution glycan separations. They provide industry-leading resolution with unique selectivities for biologically important glycans, either labeled or native, using fluorescence and/or mass spectrometry (MS) detection. Both columns separate glycans by charge and size. Additionally the GlycanPac AXR-1 columns are superior for separating glycan isomers. The GlycanPac AXH-1 columns are also used for fast, accurate, and simple quantification of glycans by charge.

8

Characterize Free GlycansYou can predict the structure of released labelled or unlabelled glycans using tandem mass spectrometry together with SimGlycan® (PREMIER Biosoft). The software automatically matches experimental mass spectra against a comprehensive database and generates a scored list of candidate structures.

ANALYZE & QUANTIFYSeparate and detect unlabeled, fluorescence labelled or glycans.

2 Minutes

Fluo

resc

ence

Cou

nts

3010 20

1 2

3

7

4

5

6

8

9

10

11

12 1415

16

neutral

monosialylated

13 170

8.5E5

Separation of labeled N-glycans from human IgG using a GlycanPac AXH-1 column.

Page 6: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

High performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) is a well-established analysis method to characterize released Glycans. The separation is exceptionally selective for sugars and resolves glycans based on charge, size, composition, isomers and linkages. It is even possible to separate glycans based on sialic acid linkage, providing valuable information not only about the sugar sequence of a glycan, but also the subtle linkage differences that may indicate disease states.

INTACT GLYCOPROTEINIsolated antibody or glycoprotein.

INTACT GLYCOPROTEINIsolated antibody or glycoprotein.

RELEASE GLYCANSGlycans are released enzymatically using glycosidase.

RELEASE GLYCANSGlycans are released enzymatically using glycosidase.

RELEASE MONOSACCHARIDESGlycans are released enzymatically using glycosidase. Glycans are then hydrolyzed to monosaccharides using acid.

11

COMPLEX GLYCANS ARE attached to my drug?

IS THE COMPOSITION OF sugars in my drug entity?

WHICH TYPES OF WHAT

Label-free Glycan Workflow Monosaccharide Workflow

10

HPAE-PAD

Unique CarboPac ChemistryResins of Thermo Scientific™ CarboPac™ columns consist of nonpourous beads covered witrh a fine latex of functionlized Thermo Scientific™ Dionex™ MicroBead™. This pellicular resin structure permits excellent mass transfer, resulting in high resolution chromatography and rapid reequilibration.

Highly Crosslinked Core

Latex MicroBeads with Anion Exchange Functionalities

Monosaccharide composition, namly Fucose, Galactosamine, Glucosamine, Galactose, Glucose and Mannose, is routinly determined as their number and composition bound to the protein can impact efficacy of biotherapeutics. Monosaccharides are weak acids and can be separated by anion-exchange chromatography under basic conditions. Samples are acid hydrolyzed to release monosaccharides and analyzed by HPAE-PAD after chromatographic separation with CarboPac columns.

ANALYZE USING ION CHROMATOGRAPHYSimple, sensitive glycan analysis without labelling.

0 5 10

90

nC

–5

100

nC

–50 5 10

Minutes

1

2

3

45

6

1

2

3

4 5

6

A Without Dionex BorateTrap Column

B With Dionex BorateTrap Column

The Thermo Scientific™ Dionex ICS-5000+ and ICS-4000 HPIC™ systems are ideal for HPAE PAD ion chromatography of mono-, di-, polysaccharides and sialic acids. With completely metal free flowpaths we eliminate the possibility of metal contamination and improve robustness for biomolecules. The analysis can be performed using Reagent-Free™ IC (RFIC™) systems with eluent generation that only require deionized water to electrolytically generate the eluent.

HPAE-PAD only detects those compounds that contain functional groups that become oxidized at the detection voltage employed. Detection is sensitive and highly selective for sugars, because many potentially interfering species cannot be oxidized or reduced, and are not detected.

High Performance Ion Chromatography™ for HPAE-PAD

ANALYZE USING ION CHROMATOGRAPHYUltra sensitive monosaccharide and sialic acid analysis.

0 5 10

90

nC

–5

100

nC

–50 5 10

Minutes

1

2

3

45

6

1

2

3

4 5

6

A Without Dionex BorateTrap Column

B With Dionex BorateTrap Column

0 5 10

90

nC

–5

100

nC

–50 5 10

Minutes

1

2

3

45

6

1

2

3

4 5

6

A Without Dionex BorateTrap Column

B With Dionex BorateTrap Column

25

150

nA A

Minutes

0 10 20 30 40 50

25

300

nA B

25

150

nA A

Minutes

0 10 20 30 40 50

25

300

nA B

Free unlabelled N-Linked Oligosaccharides from Monoclonal Antibody Preparations.Chromatograms:A: PNGase F digest of human polyclonal IgG B: PNGase F digest of humanized MAB M115

Page 7: Join the sweet revolution in biopharmaceuticals...resolution/accurate mass (HR/AM) mass spectrometry together with chromatographic separation to gain full insight into the various

BR64513-EN 0515S

Join the Sweet Revolution in Biopharmaceuticals visit www.thermoscientific.com/sweetrevolution

facebook.com/ChromatographySolutions twitter.com/ChromSolutions analyteguru.com

Denmark +45 70 23 62 60Europe-Other +43 1 333 50 34 0Finland +358 10 3292 200France +33 1 60 92 48 00Germany +49 6103 408 1014India +91 22 6742 9494Italy +39 02 950 591

Africa +43 1 333 50 34 0Australia +61 3 9757 4300Austria +43 810 282 206Belgium +32 53 73 42 41Canada +1 800 530 8447China 800 810 5118 (free call domestic)

400 650 5118

Japan +81 45 453 9100Korea +82 2 3420 8600Latin America +1 561 688 8700Middle East +43 1 333 50 34 0Netherlands +31 76 579 55 55New Zealand +64 9 980 6700Norway +46 8 556 468 00

Russia/CIS +43 1 333 50 34 0Singapore +65 6289 1190Spain +34 914 845 965Sweden +46 8 556 468 00Switzerland +41 61 716 77 00UK +44 1442 233555USA +1 800 532 4752

www.thermoscientific.com/glycomics©2015 Thermo Fisher Scientific Inc. All rights reserved. SimGlycan is a registered mark of PREMIER Biosoft International, USA. All other trademarks are the property of Thermo Fisher Scientific and its subsidiaries. This information is presented as an example of the capabilities of Thermo Fisher Scientific products. It is not intended to encourage use of these products in any manners that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all countries. Please consult your local sales representative for details.

Stay Ahead! Scan the QR code or follow the URL to watch the latest webinars on glycan characterization.